Loading

Journal of Preventive Medicine and Health Care

Artificial Intelligence-based Remote Electrocardiogram MonitoringImproves the Diagnosis of Arrhythmias and Reduces Morbidity Caused by Fatal Arrhythmias

Research Article | Open Access | Volume 3 | Issue 1

  • 1. Department of Cardiology, Hefei Hi-Tech Cardiovascular Hospital, Hefei, Anhui Province, China
  • 2. Division of Cardiovascular Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA
  • 3. Yocaly Enterprise, Lepu Medical, Jinan, Shandong Province, China
+ Show More - Show Less
Corresponding Authors
Li Liu and Weiyi Fang, Department of Cardiology, Hefei Hi-Tech Cardiovascular Hospital, Hefei, Anhui Province, China
Abstract

Background: Remote ECG monitoring can provide valuable information for diagnosis in patients with cardiovascular diseases (CVD), but manually studying large amounts of ECG data can be tedious and time-consuming. The aim of this study was to evaluate the values of AI-based ECG monitoring and data analysis in clinical practice.

Methods: Between January 2018 and October 2019, a total of 16,408 patients evaluated for suspected CVD at Hefei Hi-Tech Cardiovascular Hospital and its associated community hospitals/clinics underwent i-Holter, a heart remote mobile monitoring device from Yocaly Information Science & Technology Co., Ltd, Lepu Medical, China. The i-Holter monitor is a remote, AI-based, real-time heart monitoring system with built-in pre-warning functions. The ECG data obtained from remote monitoring was screened and analyzed by this AI-based ECG analysis system and the final diagnosis was confirmed by ECG specialists. The number of pre-warning alerts, classification of arrhythmias, subsequent patient management, and outcomes were also analyzed.

Results: Of the 16,408 patients, 68.3% were detected to have different arrhythmias. The most common is supraventricular arrhythmia (40.7%), followed by ventricular arrhythmia (30.2%), ST-T segmental alternation (20.5%), cardiac pause (3.7%), atrial-ventricular blockage (2.5%), and branch blockage (2.2%). A total of 3,351 patients were alerted due to reaching critical ECG values and 8,874 phone calls were taken for the alerts. Among the alerts, 37.1% were supraventricular tachycardia, 36.4% were ST-T alternation, following by atrial flutter/atrial fibrillation (7.4%), ventricular tachycardia (6.4%), sinus tachycardia (6.1%), III° A-V block (3.3%), cardiac pause (1.98%), and ventricular flutter/fibrillation (0.03%). 1,229 patients (36.7%) with alerts needed promote management and obtained good outcomes.

Conclusion: AI-based remote monitoring can manage high volume ECG data, provide prompt diagnosis with high accuracy, initiate alert timely if critical values are reached. Patients in fatal situations can be managed in a timely manner, improving patient prognosis and leading to reduced mortality.

Keywords

Artificial intelligence (AI), Arrhythmia, Electrocardiogram (ECG) monitoring, i-Holter

Citation

Liu L, Chen J, Yang F, Cao K, Fang W (2021) Artificial Intelligence-based Remote Electrocardiogram Monitoring Improves the Diagnosis of Arrhythmias and Reduces Morbidity Caused by Fatal Arrhythmias. J Prev Med Healthc 3(1): 1026.

BACKGROUND

Cardiovascular disorders (CVD) are the leading cause of death in China, being the cause of 40% of deaths in the Chinese population according to the recent data from National Center for Cardiovascular Diseases (1). Cardiac arrhythmias are remarkably common in patients with CVD, some are life-threatening, but they routinely go undiagnosed because they are often unpredictable, transient, and asymptomatic (2,3). Prompt diagnosis of these lifethreatening arrhythmias in symptomatic/asymptomatic patients and initiation of timely treatment can substantially reduce the morbidity and mortality rates associated with these arrhythmias. However, this is usually limited by several factors in clinical practice. Electrocardiogram (ECG) recordings were major tool for the diagnosis of cardiac arrhythmias and widely used by clinicians as a routine modality in hospitals, as it captures the propagation of the cardiac electrical signal from the body’s surface. Many cardiac structural or electrophysiological abnormalities have a signature on the ECG, therefore ECG analysis can be a crucial first step to help diagnose, understand, and predict cardiovascular disorders. However, a growing body of evidence has shown that the morbidity and mortality rates associated with subclinical arrhythmias are often missed by ECG or conventional 24-hour monitors (Holter) because the occurrence of arrhythmia is usually transient and unpredictive (3, 4). Also, manually studying large amounts of ECGs or Holter data can be tedious and timeconsuming; there is a long study-curve to give an accurate ECG diagnosis. Furthermore, conventional 24-hour monitors (Holter) are retrospective analysis, which is unable to give a pre-warning when life-threatening arrhythmia is occurring. Therefore, the need for a powerful method or tool that is able to monitor patients in real-time, analyze high volume of ECG data, cover long-period ECG changes, and give prompt and accurate diagnosis becomes urgent. With the progress of science and technology, automatic analysis and diagnosis systems based on electrocardiogram (ECG) signals, such as artificial intelligence (AI), have been extensively investigated in the detection and diagnosis of cardiac arrhythmias (5, 6). Studies have shown that the use of an AIassistant ECG automatic analysis and diagnosis system not only reduces the workload of doctors but also improves diagnostic efficiency and accuracy (5, 6, 14, 16-18).

Artificial intelligence (AI) is a field of computer science that aims to mimic human thought processes, learning capacity, and storage of knowledge. This computational technique, and more specifically, machine-learning technique, is a powerful tool for classification, clustering and simulation, and they have recently been applied to address the analysis of medical data, especially ECG data (14-19). In this study, we evaluated the clinical value of an AI-based remote monitoring system, i-Holter, in investigating the epidemiology of arrhythmia, helping clinical diagnosis of ECGs, and assisting doctor’s decision of treatment in patients with suspicious CVD. Our results indicated that use of this AI-based remote monitoring can provide prompt diagnosis with high accuracy, give timely alerts, and help initiate prompt treatment for severe patients.

MATERIALS AND METHODS

Patients Consecutive patients who went to the Hefei Hi-Tech Cardiovascular Hospital and its affiliated hospitals/clinics from January 2018 to October 2019 for the evaluation of associated symptoms (such as palpitation, chest pain or discomfort) were included. Inclusion criteria included any age able to comply with continuous ECG monitoring and capable of providing informed consent by themselves or by their parents. The patients’ general clinical information, including age, gender, height, weight, blood pressure, heart rate, past medical history, and personal habits (e.g., smoking, drinking) were collected. Written informed consent was obtained from all patients (or their parents if <18 years old) before enrollment. The study protocol was approved by the Ethics Committee of Hefei Hi-Tech Cardiovascular Hospital and was conducted in accordance with the ethical guidelines of the 1975 Declaration of Helsinki.

The Recordings, Monitoring and Analyzing of Remote ECG Data

i-Holter is a remote, mobile heart-monitoring system and heart real-time monitoring pre-warning device from Yocaly Information Science & Technology Co., Ltd, Lepu Medical, that has been approved by the US FDA and the EU CE certification in China. It is a three-channel Holter ECG system which can store a continuous and simultaneous recording of three-lead ECG for up to one week upon battery change (Figure 1).

 i-Holter (Lepu’s AI- ECG platform ECG diagnostic system)  has been approved by the US FDA and the EU CE certification in China.

Figure 1 i-Holter (Lepu’s AI- ECG platform ECG diagnostic system) has been approved by the US FDA and the EU CE certification in China.

Patients were asked to perform their usual daily activities while wearing the device. The ECG data was transferred automatically or manually to the Data Analysis Center of Yocally Information Science & Technology, Co., Ltd (Jinan, Shandong Province, China). An AI-based ECG analysis system would perform the first-step screening and give a primary diagnosis, then the diagnosis would be confirmed by ECG specialists. If any conflict is present, three specialists would discuss and give a consistent diagnosis.

Alerts Initiation and Management

The alert value is set according to the following standards (Table 1).

Table 1: The ECG Standards for Alert Initiation.

Severe
Arrhythmia
Tachycardia 1. Ventricular flutter/Fibrilation
2. Ventricular/ wide QRS tachycardia, HR≥150bpm, last ≥ 30s or ≤ 30s but HR ≥ 180bpm
3. Torsades De Pointes, Polymorphic VT, Bidirectional VT
4. PSVT, HR ≥ 200bpm
5. Atrial fibrillation accompanied with W-P-W syndrome, HR ≥ 200bpm
Bradycardia 6. Severe bradycardia, such as third- degree heart block, HR ≤ 35bpm
7. R-R interval ≥ 3s
Suspected ACS 8. New horizontal or down-sloping ST segment depression ≥ 0.5 mm at the J-point in ≥ 2 contiguous leads, or old 
depression becomes worse.
9. St segment depression ≥ 0.2mV at first time or become worse if ST depression present before
10. ECG changes indicating recurrence of AMI
Other Emergency Situations 11. ECG appearance of severe hyperkalemia/hypokalemia
12. Severe bradycardia, such as third-degree heart block, HR ≤ 35bpm
13. Long QT interval (≥ 480ms)
14. Premature ventricular contraction with R on T phenomena.
15. Significant T wave electric alternation

Any patient who meets the alert standards will be issued a pre-warning signal by the AI analysis system. The backend ECG analysis expert will review it at once and a phone call will be given to the primary care physicians (PCP) or patient immediately. The PCP will determine if the patients need further management, including symptomatic management, going to emergency room (ER), or receiving other interventions.

RESULTS

Study population

16,408 (6 - 95 years old, average 52.3±38.4 years) were included in this study. 51.2% of them were male, 58.2% had hypertension, 30.6% had diabetes, 26.2% had active CAD, and 13.4% had history of stroke or transient ischemic attack. 69.7% patients are from affiliated hospitals or clinics (Level II and below hospital) of Hefei Hi-Tech Cardiovascular Hospitals, of which 7,536 (45.9%) were inpatient and 8,872 were outpatient. The clinical characteristics of the overall study population are listed in (Table 2).

Table 2: Patient’s Demographic and Clinical Characteristics.

Age (years) 52.3 ± 38.4
Gender (%, male vs female) 51.2% vs 48.8%
Weight (Kg) 42.5 ± 20.6
Height (cm) 158.2 ± 19.5
Systolic BP (mmHg) 150.66 ± 19.63
Diastolic BP (mmHg) 83.78 ± 17.59
HR (bpm) 76.42 ± 20.15
Hypertension (%) 58.2
Diabetes (%) 30.6
Hyperlipidemia (%) 40.6
Active CHD (%) 26.2
Stroke or TIA (%) 13.4
COPD (%) 15.5
Renal insufficiency (%) 19.8
Smoking (%) 20.8
Alcohol (%) 19.

ECG Data Analysis

The ECG data was analyzed with AI-based ECG analysis system, then confirmed by the back-end ECG analysis experts. The results showed that 78.3% patients were detected with differing arrhythmias. Among them, atrial/supraventricular arrhythmia was the most common arrhythmia, accounting for 40.7% of the group, followed by ventricular arrhythmia (30.2%), and ST-T changes (20.5%) (Figure 2).

The Classification of Cardiac Arrhythmias Detected with i-Holter.

Figure 2 The Classification of Cardiac Arrhythmias Detected with i-Holter.

We also analyzed the gender differences of different arrhythmias between men and women. In general, there is little gender difference in various arrhythmias in different age groups, except for the ST-T segment changes in the 20-29 age group, which was seen more in female than in male (data not shown).

Alert Initiation

Alerts were initiated in 3,351 patients due to meeting the prewarning standards. Among them, 52.7% were men and a total of 8,874 calls were made for the warning. The classification of initiating alert is shown in the table (Table 3).

Table 3: The Cardiac Arrhythmias Initiating Alerts (n = 3351).

Supraventricular Arrhythmias 1454 (43.4%)
ST Segment changes 921 (27.5%)
Artial flutter/ fibrillation 322 (9.6%)
High degree A-V block 201 (6.0%)
Severe Bradycardia 175 (5.2%)
Ventricular Tachycardia 174 (5.2%)
Cardiac Pause 54 (1.6%)
Long QT interval (≥ 480ms) 44 (1.3%)
Ventricular flutter/ Fibrillation 6 (0.18%)

Supraventricular tachycardia is the most common causes for alert initiation, accounting for 43.4% of the cases, followed by ST segment changes (27.5%), atrial flutter/fibrillation (9.6%), atrioventricular block (6.0%), and severe bradycardia (5.3%).

Among all alerts, 1,229 patients (36.7%) received urgent management, including medical observation and management, transferring to emergency room, receiving early intervention (e.g pacemaker implantation, coronary angiography/PCI intervention, radiofrequency ablation, electric defibrillation, etc.) (Figure 3).

 The Management of Patients with Alerts Initiation.

Figure 3 The Management of Patients with Alerts Initiation.

All patients have achieved good outcome except for four sudden deaths. A representative case initiating alerts due to ST-T elevation (acute myocardial infarction) is shown on (Figure 4).

A representative case of i-Holter monitoring, alert initiation  and patient management.

Figure 4 A representative case of i-Holter monitoring, alert initiation and patient management.

DISCUSSION

Remote real-time ECG monitoring is a technology that has developed rapidly in the medical field in recent years. Studies have shown that it has great advantages in health service improvement, disease diagnosis, and patient transfer (7, 8). ECG remote monitoring can be used for many diseases, such as patients with heart device implantation, chronic lung disease, diabetes, and particularly the patients with cardiovascular and cerebrovascular diseases (7-11). Rapid and accurate alerts during ECG monitoring in patients with life-threatening situations, such as acute myocardial infarction, fatal arrhythmias, etc., are very important in saving the patient’s life and improving prognosis through initiating the therapeutic process in a timely manner. However, traditional ECG monitoring equipment, such as the Holter detector, is a retrospective diagnosis (4, 12); the diagnostic report usually comes out 24 hours later, and the positive rate of diagnosis is only 5-18% (12-14), therefore it cannot provide accurate, early alerts of critical events in time. Recent studies have shown that AI-based ECG analysis has several advantages when compared to traditional Holter monitoring:

1) the diagnostic speed of arrhythmias by AI is significantly higher than that by specialists,

2) it can analyze high-volume ECG data in a short period of time, and

3) the accuracy of diagnosis by AI is equal to or even higher than that by professionals (6, 14, 15).

In this study, we analyzed the data from an AI-based ECG remote monitoring equipment (i-Holter). Among 16,408 patients, 3,350 patients were alerted due to critical ECG values and subsequently, 8,874 phone calls were made for the alerts. All fatal situations were managed properly (e.g., pacemaker implantation, stents for AMI, defibrillation for fatal ventricular arrhythmias, and medical treatment for supraventricular tachycardia). Our results suggested that AI-based ECG remote monitoring can monitor patients large-scale, analyze high volumes of data, detect and diagnose the arrhythmias in a rapid and accurate manner, and initiate the alert for fatal arrhythmias in time, therefore saving lives and reducing mortality.

AI-ECG technology can effectively process interference signals and reduce the impact of interference on the accuracy of image judgment, support 72 special ECG diagnosis types with more detailed judgment, high accuracy and stability, and it will not suffer from quality degradation due to long working hours as well (6, 16-18). The average time for traditional manual analysis of a 24-hour Holter electrocardiogram is 20-30 minutes, while the AI-ECG algorithm analysis time for a 24-hour Holter electrocardiogram is about 1-5 minutes (15). Fast speed and high accuracy rates can greatly reduce the overall analysis time. This i-Holter AI-based ECG analysis system comes from nearly 30 million accurately labeled data fragments of 300,000 patients. Using 1 million independent test data for testing, the accuracy rate can reach 95.2%. For some special arrhythmias, such as atrial fibrillation, the positive prediction rate can reach 99%, which is significantly higher than traditional analysis (~70%) (15). The analysis and early warnings can automatically track the dynamic change trend of patient data according to the different physical conditions of each patient, and deduce the personalized alarm threshold, which greatly improves the effective early warning rate and reduces false alarms (15).

In conclusion, i-Holter is a reliable real-time ECG remote monitoring equipment that can provide rapid early warning and accurate diagnosis, and help clinicians manage patients efficiently, thus improving patients’ prognosis and reducing mortality. This AI-based ECG monitoring system can provide a low-cost and effective solution to the challenges of high-volume ECG data analysis and the need for a rapid and accurate diagnosis.

CONFLICT OF INTERESTS STATEMENT

The authors declare no conflict or competing interest with respect to the authorship and publication of this article. The authors have no financial relationship with any organization.

DISCLOSURE OF FUNDING SUPPORT

This manuscript did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

CONSENT FOR PUBLICATION

All authors have read and agreed to the published version of the manuscript.

REFERENCES

1. Hu S, Gao R, Liu L, Zhu M, Wang W, et al. represent the China Cardiovascular Disease Report Writing Group. Summary of “China Cardiovascular Disease Report 2018”. Chinese Circulation Journal. 2019; 34: 209-220.

2. Barrett PM, Komatireddy R, Haaser S, Topol S, Sheard J, et al. Comparison of 24-hour Holter monitoring with 14-day novel adhesive patch electrocardiographic monitoring. Am J Med. 2014; 127: 95.

3. Healey JS, Connolly SJ, Gold MR, Israel CW, Van Gelder IC, et al. Subclinical atrial fibrillation and the risk of stroke. N Engl J Med. 2012; 366: 120-129.

4. Reiffel JA, Schwarzberg R, Murry M. Comparison of autotriggered memory loop recorders versus standard loop recorders versus 24- hour Holter monitors for arrhythmia detection. Am J Cardiol. 2005; 95: 1055-1059.

5. Edla S, Kovvali N, Papandreou-Suppappola A. Electrocardiogram signal modeling with adaptive parameter estimation using sequential bayesian methods. IEEE Trans. Signal Process. 2014; 62: 2667–2680.

6. Jain S, Bajaj V, Kumar A. Efficient algorithm for classification of electrocardiogram beats based on artificial bee colony-based least squares support vector machines classifier. Electron. Lett. 2016; 52: 1198–1200. 

7. Martirosyan M, Caliskan K, Theuns DA, SziliTorok T. Remote monitoring of heart failure: benefits for therapeutic decision making. Expert Review of Cardiovascular Therapy. 2017; 15: 503–515.

8. De San Miguel K, Smith J, Lewin G. Telehealth remote monitoring for community-dwelling older adults with chronic obstructive pulmonary disease. Telemed J E Health. 2013; 19: 652–627.

9. Parahuleva MS, Soydan N, Divchev D, Lüsebrink U, Schieffer B, et al. Home monitoring after ambulatory implanted primary cardiac implantable electronic devices: The home ambulance pilot study. Clin Cardiol. 2017; 40: 1068-1075.

10. Wakefield BJ, Holman JE, Ray A, et al. Outcomes of a home telehealth intervention for patients with diabetes and hypertension. Telemed J E Health. 2012; 18: 575–579.

11. Kurka N, Bobinger T, Kallmünzer B, Koehn J, Schellinger PD, et al. Reliability and limitations of automated arrhythmia detection in telemetric monitoring after stroke. Stroke. 2015; 46: 560-563.

12. Kinlay S, Leitch JW, Neil A, Chapman BL, Hardy DB, et al. Cardiac event recorders yield more diagnoses and are more cost-effective than 48- hour Holter monitoring in patients with palpitations. Ann Intern Med. 1996; 124: 16-20.

13. Scalvini S, Zanelli E, Martinelli G, Baratti D, Giordano A, et al. Cardiac event recording yields more diagnoses than 24-hour Holter monitoring in patients with palpitations. J Telemed Telecare. 2005; 11: 14-16.

14. Hannun AY, Rajpurkar P, Haghpanahi M, Tison GH, Bourn C, et al. Cardiologist-level arrhythmia detection and classification in ambulatory electrocardiograms using a deep neural network. Nat Med. 2019; 25: 65-69.

15. The data test results are derived from the real test data of Lepu Medical AI-ECG during the FDA application process.

16. Chakroborty S. Accurate arrhythmia classification using autoassociative neural network. Annu Int Conf IEEE Eng Med Biol Soc. 2013; 2013: 4247-4250.

17. Li H, Yuan D, Wang Y, Cui D, Cao L. Arrhythmia Classification Based on Multi-Domain Feature Extraction for an ECG Recognition System. Sensors (Basel). 2016; 16: 1744.

18. Zadeh AE & Khazaee A. High efficient system for automatic classification of the electrocardiogram beats. Ann Biomed Eng. 2011; 39: 996–1011

Liu L, Chen J, Yang F, Cao K, Fang W (2021) Artificial Intelligence-based Remote Electrocardiogram Monitoring Improves the Diagnosis of Arrhythmias and Reduces Morbidity Caused by Fatal Arrhythmias. J Prev Med Healthc 3(1): 1026

Received : 08 Sep 2021
Accepted : 28 Sep 2021
Published : 30 Sep 2021
Journals
Annals of Otolaryngology and Rhinology
ISSN : 2379-948X
Launched : 2014
JSM Schizophrenia
Launched : 2016
Journal of Nausea
Launched : 2020
JSM Internal Medicine
Launched : 2016
JSM Hepatitis
Launched : 2016
JSM Oro Facial Surgeries
ISSN : 2578-3211
Launched : 2016
Journal of Human Nutrition and Food Science
ISSN : 2333-6706
Launched : 2013
JSM Regenerative Medicine and Bioengineering
ISSN : 2379-0490
Launched : 2013
JSM Spine
ISSN : 2578-3181
Launched : 2016
Archives of Palliative Care
ISSN : 2573-1165
Launched : 2016
JSM Nutritional Disorders
ISSN : 2578-3203
Launched : 2017
Annals of Neurodegenerative Disorders
ISSN : 2476-2032
Launched : 2016
Journal of Fever
ISSN : 2641-7782
Launched : 2017
JSM Bone Marrow Research
ISSN : 2578-3351
Launched : 2016
JSM Mathematics and Statistics
ISSN : 2578-3173
Launched : 2014
Journal of Autoimmunity and Research
ISSN : 2573-1173
Launched : 2014
JSM Arthritis
ISSN : 2475-9155
Launched : 2016
JSM Head and Neck Cancer-Cases and Reviews
ISSN : 2573-1610
Launched : 2016
JSM General Surgery Cases and Images
ISSN : 2573-1564
Launched : 2016
JSM Anatomy and Physiology
ISSN : 2573-1262
Launched : 2016
JSM Dental Surgery
ISSN : 2573-1548
Launched : 2016
Annals of Emergency Surgery
ISSN : 2573-1017
Launched : 2016
Annals of Mens Health and Wellness
ISSN : 2641-7707
Launched : 2017
Journal of Chronic Diseases and Management
ISSN : 2573-1300
Launched : 2016
Annals of Vaccines and Immunization
ISSN : 2378-9379
Launched : 2014
JSM Heart Surgery Cases and Images
ISSN : 2578-3157
Launched : 2016
Annals of Reproductive Medicine and Treatment
ISSN : 2573-1092
Launched : 2016
JSM Brain Science
ISSN : 2573-1289
Launched : 2016
JSM Biomarkers
ISSN : 2578-3815
Launched : 2014
JSM Biology
ISSN : 2475-9392
Launched : 2016
Archives of Stem Cell and Research
ISSN : 2578-3580
Launched : 2014
Annals of Clinical and Medical Microbiology
ISSN : 2578-3629
Launched : 2014
JSM Pediatric Surgery
ISSN : 2578-3149
Launched : 2017
Journal of Memory Disorder and Rehabilitation
ISSN : 2578-319X
Launched : 2016
JSM Tropical Medicine and Research
ISSN : 2578-3165
Launched : 2016
JSM Head and Face Medicine
ISSN : 2578-3793
Launched : 2016
JSM Cardiothoracic Surgery
ISSN : 2573-1297
Launched : 2016
JSM Bone and Joint Diseases
ISSN : 2578-3351
Launched : 2017
JSM Bioavailability and Bioequivalence
ISSN : 2641-7812
Launched : 2017
JSM Atherosclerosis
ISSN : 2573-1270
Launched : 2016
Journal of Genitourinary Disorders
ISSN : 2641-7790
Launched : 2017
Journal of Fractures and Sprains
ISSN : 2578-3831
Launched : 2016
Journal of Autism and Epilepsy
ISSN : 2641-7774
Launched : 2016
Annals of Marine Biology and Research
ISSN : 2573-105X
Launched : 2014
JSM Health Education & Primary Health Care
ISSN : 2578-3777
Launched : 2016
JSM Communication Disorders
ISSN : 2578-3807
Launched : 2016
Annals of Musculoskeletal Disorders
ISSN : 2578-3599
Launched : 2016
Annals of Virology and Research
ISSN : 2573-1122
Launched : 2014
JSM Renal Medicine
ISSN : 2573-1637
Launched : 2016
Journal of Muscle Health
ISSN : 2578-3823
Launched : 2016
JSM Genetics and Genomics
ISSN : 2334-1823
Launched : 2013
JSM Anxiety and Depression
ISSN : 2475-9139
Launched : 2016
Clinical Journal of Heart Diseases
ISSN : 2641-7766
Launched : 2016
Annals of Medicinal Chemistry and Research
ISSN : 2378-9336
Launched : 2014
JSM Pain and Management
ISSN : 2578-3378
Launched : 2016
JSM Women's Health
ISSN : 2578-3696
Launched : 2016
Clinical Research in HIV or AIDS
ISSN : 2374-0094
Launched : 2013
Journal of Endocrinology, Diabetes and Obesity
ISSN : 2333-6692
Launched : 2013
Journal of Substance Abuse and Alcoholism
ISSN : 2373-9363
Launched : 2013
JSM Neurosurgery and Spine
ISSN : 2373-9479
Launched : 2013
Journal of Liver and Clinical Research
ISSN : 2379-0830
Launched : 2014
Journal of Drug Design and Research
ISSN : 2379-089X
Launched : 2014
JSM Clinical Oncology and Research
ISSN : 2373-938X
Launched : 2013
JSM Bioinformatics, Genomics and Proteomics
ISSN : 2576-1102
Launched : 2014
JSM Chemistry
ISSN : 2334-1831
Launched : 2013
Journal of Trauma and Care
ISSN : 2573-1246
Launched : 2014
JSM Surgical Oncology and Research
ISSN : 2578-3688
Launched : 2016
Annals of Food Processing and Preservation
ISSN : 2573-1033
Launched : 2016
Journal of Radiology and Radiation Therapy
ISSN : 2333-7095
Launched : 2013
JSM Physical Medicine and Rehabilitation
ISSN : 2578-3572
Launched : 2016
Annals of Clinical Pathology
ISSN : 2373-9282
Launched : 2013
Annals of Cardiovascular Diseases
ISSN : 2641-7731
Launched : 2016
Journal of Behavior
ISSN : 2576-0076
Launched : 2016
Annals of Clinical and Experimental Metabolism
ISSN : 2572-2492
Launched : 2016
Clinical Research in Infectious Diseases
ISSN : 2379-0636
Launched : 2013
JSM Microbiology
ISSN : 2333-6455
Launched : 2013
Journal of Urology and Research
ISSN : 2379-951X
Launched : 2014
Journal of Family Medicine and Community Health
ISSN : 2379-0547
Launched : 2013
Annals of Pregnancy and Care
ISSN : 2578-336X
Launched : 2017
JSM Cell and Developmental Biology
ISSN : 2379-061X
Launched : 2013
Annals of Aquaculture and Research
ISSN : 2379-0881
Launched : 2014
Clinical Research in Pulmonology
ISSN : 2333-6625
Launched : 2013
Journal of Immunology and Clinical Research
ISSN : 2333-6714
Launched : 2013
Annals of Forensic Research and Analysis
ISSN : 2378-9476
Launched : 2014
JSM Biochemistry and Molecular Biology
ISSN : 2333-7109
Launched : 2013
Annals of Breast Cancer Research
ISSN : 2641-7685
Launched : 2016
Annals of Gerontology and Geriatric Research
ISSN : 2378-9409
Launched : 2014
Journal of Sleep Medicine and Disorders
ISSN : 2379-0822
Launched : 2014
JSM Burns and Trauma
ISSN : 2475-9406
Launched : 2016
Chemical Engineering and Process Techniques
ISSN : 2333-6633
Launched : 2013
Annals of Clinical Cytology and Pathology
ISSN : 2475-9430
Launched : 2014
JSM Allergy and Asthma
ISSN : 2573-1254
Launched : 2016
Journal of Neurological Disorders and Stroke
ISSN : 2334-2307
Launched : 2013
Annals of Sports Medicine and Research
ISSN : 2379-0571
Launched : 2014
JSM Sexual Medicine
ISSN : 2578-3718
Launched : 2016
Annals of Vascular Medicine and Research
ISSN : 2378-9344
Launched : 2014
JSM Biotechnology and Biomedical Engineering
ISSN : 2333-7117
Launched : 2013
Journal of Hematology and Transfusion
ISSN : 2333-6684
Launched : 2013
JSM Environmental Science and Ecology
ISSN : 2333-7141
Launched : 2013
Journal of Cardiology and Clinical Research
ISSN : 2333-6676
Launched : 2013
JSM Nanotechnology and Nanomedicine
ISSN : 2334-1815
Launched : 2013
Journal of Ear, Nose and Throat Disorders
ISSN : 2475-9473
Launched : 2016
JSM Ophthalmology
ISSN : 2333-6447
Launched : 2013
Journal of Pharmacology and Clinical Toxicology
ISSN : 2333-7079
Launched : 2013
Annals of Psychiatry and Mental Health
ISSN : 2374-0124
Launched : 2013
Medical Journal of Obstetrics and Gynecology
ISSN : 2333-6439
Launched : 2013
Annals of Pediatrics and Child Health
ISSN : 2373-9312
Launched : 2013
JSM Clinical Pharmaceutics
ISSN : 2379-9498
Launched : 2014
JSM Foot and Ankle
ISSN : 2475-9112
Launched : 2016
JSM Alzheimer's Disease and Related Dementia
ISSN : 2378-9565
Launched : 2014
Journal of Addiction Medicine and Therapy
ISSN : 2333-665X
Launched : 2013
Journal of Veterinary Medicine and Research
ISSN : 2378-931X
Launched : 2013
Annals of Public Health and Research
ISSN : 2378-9328
Launched : 2014
Annals of Orthopedics and Rheumatology
ISSN : 2373-9290
Launched : 2013
Journal of Clinical Nephrology and Research
ISSN : 2379-0652
Launched : 2014
Annals of Community Medicine and Practice
ISSN : 2475-9465
Launched : 2014
Annals of Biometrics and Biostatistics
ISSN : 2374-0116
Launched : 2013
JSM Clinical Case Reports
ISSN : 2373-9819
Launched : 2013
Journal of Cancer Biology and Research
ISSN : 2373-9436
Launched : 2013
Journal of Surgery and Transplantation Science
ISSN : 2379-0911
Launched : 2013
Journal of Dermatology and Clinical Research
ISSN : 2373-9371
Launched : 2013
JSM Gastroenterology and Hepatology
ISSN : 2373-9487
Launched : 2013
Annals of Nursing and Practice
ISSN : 2379-9501
Launched : 2014
JSM Dentistry
ISSN : 2333-7133
Launched : 2013
Author Information X